Erratum: Maternal HCV infection is associated with intrauterine fetal growth disturbance: A meta-analysis of observational studies (Medicine and Science in Sports and Exercise (2016) 95:35 (e4777) DOI: 10.1097/MD.0000000000004777);Maternal HCV infection is associated with intrauterine fetal growth disturbance A meta-analysis of observational studies

Medicine (United States)

Volumn 95, Issue 35, 2016, Pages e266c-

  Huang, Qi Tao ^a,b   Hang, Li Lin ^b   Zhong, Mei ^a   Gao, Yun Fei ^a   Luo, Man Ling ^a   Yu, Yan Hong ^a  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

^b Division of Obstetrics and Gynecology   (China)

Author keywords

Hepatitis C virus; Intrauterine fetal growth restriction; Low birth weight

Indexed keywords

ALCOHOL ABUSE; ARTICLE; CLINICAL PRACTICE; DISEASE ASSOCIATION; DRUG ABUSE; HEPATITIS B; HEPATITIS C; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MATERNAL AGE; MATERNAL SMOKING; MIXED INFECTION; PARITY; PREECLAMPSIA; PRIORITY JOURNAL; SYSTEMATIC REVIEW; ADVERSE EFFECTS; ALCOHOLISM; COMPLICATION; DRUG DEPENDENCE; FEMALE; META ANALYSIS; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; RISK FACTOR; SMOKING; VIROLOGY;

ALCOHOLISM; COINFECTION; FEMALE; FETAL GROWTH RETARDATION; HEPATITIS C; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MATERNAL AGE; PARITY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; SMOKING; SUBSTANCE-RELATED DISORDERS;

EID: 84987728097     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/01.MD.0000503452.53226.6C     Document Type: Erratum

References (56)

1. Messina JP, Humphreys I, Flaxman A, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 2015;61:77-87.
2. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999;6:35-47.
3. Pothineni NV, Delongchamp R, Vallurupalli S, et al. Impact of hepatitis C seropositivity on the risk of coronary heart disease events. Am J Cardiol 2014;114:1841-5.
4. Huang J, Magnusson M, Törner A, et al. Risk of pancreatic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden. Br J Cancer 2013;109:2917-23.
5. Sifer C, Benifla JL, Branger M, et al. Effects of hepatitis C virus on the apoptosis percentage of granulosa cells in vivo in women undergoing IVF: preliminary results. Hum Reprod 2002;17:1773-6.
6. Nie QH, Gao LH, Cheng YQ, et al. Hepatitis C virus infection of human cytotrophoblasts cultured in vitro. J Med Virol 2012;84:1586-92.
7. Hurtado CW, Golden-Mason L, Brocato M, et al. Innate immune function in placenta and cord blood of hepatitis C-seropositive motherinfant dyads. PLoS ONE 2010;5:e12232.
8. Butt AA, Xiaoqiang W, Budoff M, et al. Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis 2009;49:225-32.
9. Murthy GD, Vu K, Venugopal S. Prevalence and treatment of hyperlipidemia in patients with chronic hepatitis C infection. Eur J Gastroenterol Hepatol 2009;21:902-7.
10. Paroli M, Iannucci G, Accapezzato D. Hepatitis C virus infection and autoimmune diseases. Int J Gen Med 2012;5:903-7.
11. Adinolfi LE, Restivo L, Guerrera B, et al. Chronic HCV infection is a risk factor of ischemic stroke. Atherosclerosis 2013;231:22-6.
12. Lee MH, Yang HI, Wang CH, et al. Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke 2010;41:2894-900.
13. Prasad MR, Honegger JR. Hepatitis C virus in pregnancy. AmJ Perinatol 2013;30:149-59.
14. Urbanus AT, van Keep M, Matser AA, et al. Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective? PLoS ONE 2013;8:e70319.
15. McDonald SD,Han Z, Mulla S, et al. Overweight and obesity in mothers and risk of preterm birth and low birth weight infants: systematic review and meta-analyses. BMJ 2010;341:c3428.
16. Unterscheider J, Daly S, Geary MP, et al. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. Am J Obstet Gynecol 2013;208:290. e1-6.
17. Katz J, Lee AC, Kozuki N, et al. Mortality risk in preterm and small-forgestational-age infants in low-income and middle-income countries: a pooled country analysis. Lancet 2013;382:417-25.
18. Bassani DG, Kumar R, et al. Million Death Study CollaboratorsCauses of neonatal and child mortality in India: a nationally representative mortality survey. Lancet 2010;376:1853-60.
19. Unterscheider J, O'Donoghue K, Daly S, et al. Fetal growth restriction and the risk of perinatal mortality-case studies from the multicenter PORTO study. BMC Pregnancy Childbirth 2014;14:63.
20. Luyckx VA, Bertram JF, Brenner BM, et al. Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet 2013;382:273-83.
21. Visentin S, Grumolato F, Nardelli GB, et al. Early origins of adult disease: low birth weight and vascular remodeling. Atherosclerosis 2014;237: 391-9.
22. Burnett AC, Anderson PJ, Cheong J, et al. Prevalence of psychiatric diagnoses in preterm and full-term children, adolescents and young adults: a meta-analysis. Psychol Med 2011;41:2463-74.
23. Ananth CV, Vintzileos AM. Ischemic placental disease: epidemiology and risk factors. Eur J Obstet Gynecol Reprod Biol 2011;159:77-82.
24. Zhao M, Chen YH, Dong XT, et al. Folic acid protects against lipopolysaccharide-induced preterm delivery and intrauterine growth restriction through its anti-inflammatory effect in mice. PLoS ONE 2013;8:e82713.
25. Cotechini T, Komisarenko M, Sperou A, et al. Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia. J Exp Med 2014;211: 165-79.
26. Baschat AA. Fetal responses to placental insufficiency: an update. BJOG 2004;111:1031-41.
27. Adinolfi LE, Zampino R, Restivo L, et al. Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms. World J Gastroenterol 2014;20:3410-7.
28. Connell LE, Salihu HM, Salemi JL, et al. Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes. Liver Int 2011;31: 1163-70.
29. Reddick KL, Jhaveri R, GandhiM, et al. Pregnancy outcomes associated with viral hepatitis. J Viral Hepat 2011;18:e394-8.
30. Pergam SA, Wang CC, Gardella CM, et al. Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort. Am J Obstet Gynecol 2008;199:38. e1-9.
31. Berkley EM, Leslie KK, Arora S, et al. Chronic hepatitis C in pregnancy. Obstet Gynecol 2008;112(2 Pt 1):304-10.
32. Salemi JL, Whiteman VE, August EM, et al. Maternal hepatitis B and hepatitis C infection and neonatal neurological outcomes. J Viral Hepat 2014;21:e144-53.
33. Khaskheli M, Baloch S, Farooq S. Hepatitis C in haemorrhagic obstetrical emergencies. J Coll Physicians Surg Pak 2014;24:178-81.
34. Kumar A, Sharma KA, Gupta RK, et al. Pregnancy outcome in hepatitis C virus infection. Int J Gynaecol Obstet 2007;98:155-6.
35. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions, version 5. 1. 0 [Updated March 2011]. The Cochrane Collaboration. 2011.
36. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
37. Wells G, Shea BO, Connell D. (2010). The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analysis. Available at: http://www. ohri. ca/programs/clinical-epidemiol ogy/oxford-web. ppt.
38. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
39. Egger M, Smith GD. Bias in location and selection of studies. BMJ 1998;316:61-6.
40. Floreani A. Hepatitis C and pregnancy. World J Gastroenterol 2013; 19:6714-20.
41. Serfaty L, Capeau J. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data. Liver Int 2009;29(suppl 2):13-25.
42. Vespasiani-Gentilucci U, Gallo P, De Vincentis A, et al. Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis. World J Gastroenterol 2014;20:2825-38.
43. Kaukola T, Herva R, Perhomaa M, et al. Population cohort associating chorioamnionitis, cord inflammatory cytokines and neurologic outcome in very preterm, extremely low birth weight infants. Pediatr Res 2006;59:478-83.
44. Kovo M, Schreiber L, Bar J. Placental vascular pathology as amechanism of disease in pregnancy complications. Thromb Res 2013;131(suppl 1): S18-21.
45. Kovo M, Schreiber L, Ben-Haroush A, et al. Placental vascular lesion differences in pregnancy-induced hypertension and normotensive fetal growth restriction. Am J Obstet Gynecol 2010;202:561. e1-5.
46. Nkwabong E, Kamgnia Nounemi N, Sando Z, et al. Risk factors and placental histopathological findings of term born low birth weight neonates. Placenta 2015;36:138-41.
47. Kovo M, Schreiber L, Ben-Haroush A, et al. The placental factor in earlyand late-onset normotensive fetal growth restriction. Placenta 2013;34:320-4.
48. Pinar H, Goldenberg RL, Koch MA, et al. Placental findings in singleton stillbirths. Obstet Gynecol 2014;123(2 Pt 1):325-36.
49. Bröms G, Granath F, Linder M, et al. Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure. Inflamm Bowel Dis 2014;20:1091-8.
50. Nørgaard M, Larsson H, Pedersen L, et al. Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J Intern Med 2010;268:329-37.
51. SchimmelMS, Bromiker R, Hammerman C, et al. The effects of maternal age and parity on maternal and neonatal outcome. Arch Gynecol Obstet 2014;291:793-8.
52. Yu Z, Han S, Zhu J, et al. Pre-pregnancy body mass index in relation to infant birth weight and offspring overweight/obesity: a systematic review and meta-analysis. PLoS ONE 2013;8:e61627.
53. Been JV, Nurmatov UB, Cox B, et al. Effect of smoke-free legislation on perinatal and child health: a systematic review and meta-analysis. Lancet 2014;383:1549-60.
54. Pfinder M, Kunst AE, Feldmann R, et al. Preterm birth and small for gestational age in relation to alcohol consumption during pregnancy: stronger associations among vulnerable women? Results from two large Western-European studies. BMC Pregnancy Childbirth 2013;13:49.
55. Pinto SM, Dodd S, Walkinshaw SA, et al. Substance abuse during pregnancy: effect on pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol 2010;150:137-41.
56. Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol 1998;105:836-48.